• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算和分析时间比例作为衡量纵向癌症筛查依从性的方法学考虑因素。

Methodologic Considerations in Calculating and Analyzing Proportion of Time Covered as a Measure of Longitudinal Cancer Screening Adherence.

机构信息

Kaiser Permanente Washington Health Research Institute, Seattle, Washington.

Department of Epidemiology, University of Washington, Seattle, Washington.

出版信息

Cancer Epidemiol Biomarkers Prev. 2020 Aug;29(8):1549-1556. doi: 10.1158/1055-9965.EPI-20-0388. Epub 2020 May 28.

DOI:10.1158/1055-9965.EPI-20-0388
PMID:32467346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7415680/
Abstract

BACKGROUND

Proportion of time covered (PTC, or "covered time") is a longitudinal measure of adherence to preventive health services, the use of which has increased in recent years. This measure is helpful for evaluating the success of delivering screening interventions over time. However, there are challenges and nuances in computing and interpreting PTC.

METHODS

In this manuscript, we describe some desired properties of PTC measures, challenges in achieving those, and potential solutions using hypothetical examples.

RESULTS

We propose a modified PTC measure (mPTC) to complement the standard, existing PTC measure. The mPTC measure focuses on screening completion rather than initiation when a screening modality requires more than one step; is affected less by loss to follow-up, death, or cancer during covered time than the standard PTC measure; and is not sensitive to screening episode results. We propose weighting strategies to ensure that the average PTC and mPTC are more heavily influenced by individuals who were observed for longer and are thus more informative. We further describe how PTC and mPTC measures can incorporate test indication to focus specifically on screening.

CONCLUSIONS

We recommend that studies of covered time present ample descriptive information, calculate both PTC and mPTC, describe how symptoms and indication are handled, and present multiple complementary measures, such as the proportion never screened and the proportion in need of screening.

IMPACT

Common approaches, terminology, and reporting practices for covered time measures have the potential to improve the study of longitudinal cancer screening adherence.

摘要

背景

时间覆盖率(PTC,或“覆盖时间”)是衡量预防保健服务依从性的纵向指标,近年来其应用有所增加。该指标有助于评估随时间推移提供筛查干预的效果。然而,计算和解释 PTC 存在挑战和细微差别。

方法

在本文中,我们描述了 PTC 指标的一些理想属性、实现这些属性的挑战以及使用假设示例的潜在解决方案。

结果

我们提出了一种改良的 PTC 指标(mPTC)来补充标准的现有 PTC 指标。mPTC 指标在筛查模式需要多个步骤时,更侧重于筛查完成而不是启动;在覆盖时间内,受随访丢失、死亡或癌症影响小于标准 PTC 指标;并且不受筛查期结果的影响。我们提出了加权策略,以确保平均 PTC 和 mPTC 受观察时间更长的个体的影响更大,从而更具信息量。我们进一步描述了 PTC 和 mPTC 指标如何纳入测试指标,以专门关注筛查。

结论

我们建议对覆盖时间的研究提供充足的描述性信息,计算 PTC 和 mPTC,描述症状和指标的处理方式,并呈现多种互补指标,如从未接受过筛查的比例和需要筛查的比例。

影响

覆盖时间指标的常见方法、术语和报告实践有可能改善对纵向癌症筛查依从性的研究。

相似文献

1
Methodologic Considerations in Calculating and Analyzing Proportion of Time Covered as a Measure of Longitudinal Cancer Screening Adherence.计算和分析时间比例作为衡量纵向癌症筛查依从性的方法学考虑因素。
Cancer Epidemiol Biomarkers Prev. 2020 Aug;29(8):1549-1556. doi: 10.1158/1055-9965.EPI-20-0388. Epub 2020 May 28.
2
Adherence to colorectal cancer screening measured as the proportion of time covered.以时间覆盖率衡量的结直肠癌筛查依从性。
Gastrointest Endosc. 2018 Aug;88(2):323-331.e2. doi: 10.1016/j.gie.2018.02.023. Epub 2018 Feb 23.
3
Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.流行病学方法与应用概述:观察性研究设计的优势与局限性。
Crit Rev Food Sci Nutr. 2010;50 Suppl 1(s1):10-2. doi: 10.1080/10408398.2010.526838.
4
Challenges and Approaches to Measuring Repeat Fecal Immunochemical Test for Colorectal Cancer Screening.测量结直肠癌筛查重复粪便免疫化学试验的挑战和方法。
Cancer Epidemiol Biomarkers Prev. 2020 Aug;29(8):1557-1563. doi: 10.1158/1055-9965.EPI-20-0230. Epub 2020 May 26.
5
Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior.髓样肿瘤和乳头状肿瘤常出现在同一个甲状腺中,且没有证据表明它们的生物学行为存在相互影响。
Thyroid. 2004 Nov;14(11):946-52. doi: 10.1089/thy.2004.14.946.
6
Measures of longitudinal adherence to fecal-based colorectal cancer screening: Literature review and recommended approaches.基于粪便的结直肠癌筛查纵向依从性的测量:文献回顾与推荐方法。
Int J Cancer. 2021 Jul 15;149(2):316-326. doi: 10.1002/ijc.33589. Epub 2021 Apr 17.
7
Papillary thyroid microcarcinoma and papillary thyreoid cancer at the Department of Surgery, EUC Clinic Zlín.外科,兹林 EUC 诊所的甲状腺微小乳头状癌和甲状腺乳头状癌。
Rozhl Chir. 2020 Winter;99(11):487-491.
8
Hepatocellular carcinoma surveillance, early detection and survival in a privately insured US cohort.肝细胞癌监测、早期检测和生存在美国私人保险队列中。
Liver Int. 2020 Apr;40(4):947-955. doi: 10.1111/liv.14379. Epub 2020 Jan 26.
9
Multifocal papillary thyroid carcinoma--a consensus report of the European Society of Endocrine Surgeons (ESES).多灶性甲状腺乳头状癌——欧洲内分泌外科学会(ESES)的共识报告。
Langenbecks Arch Surg. 2014 Feb;399(2):141-54. doi: 10.1007/s00423-013-1145-7. Epub 2013 Nov 22.
10
Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.在一项有组织的结直肠癌筛查计划中,免疫化学粪便潜血试验与愈创木脂粪便潜血试验的纵向依从性比较。
Cancer Prev Res (Phila). 2019 May;12(5):327-334. doi: 10.1158/1940-6207.CAPR-18-0091. Epub 2019 Mar 19.

引用本文的文献

1
Imaging Surveillance Adherence After Endovascular Abdominal Aortic Aneurysm Repair at VA Hospitals.退伍军人事务部医院腹主动脉瘤血管内修复术后的影像监测依从性
JAMA Netw Open. 2025 Apr 1;8(4):e256852. doi: 10.1001/jamanetworkopen.2025.6852.
2
Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system.在综合医疗体系中进行癌症基因检测后,对乳腺癌监测的长期依从性。
Breast Cancer Res Treat. 2023 Oct;201(3):461-470. doi: 10.1007/s10549-023-07007-w. Epub 2023 Jul 20.
3
Measuring longitudinal adherence to screening needs international standards.衡量筛查的长期依从性需要国际标准。
Breast. 2023 Feb;67:129. doi: 10.1016/j.breast.2022.09.011. Epub 2022 Oct 3.
4
The COMPASS study: A prospective, randomized, multi-center trial testing the impact of a clinic-based intervention informing patients of colorectal cancer screening options on screening completion.COMPASS 研究:一项前瞻性、随机、多中心试验,旨在测试基于诊所的干预措施对告知患者结直肠癌筛查选择对筛查完成的影响。
Contemp Clin Trials. 2022 Aug;119:106852. doi: 10.1016/j.cct.2022.106852. Epub 2022 Jul 13.
5
A Centralized Program with Stepped Support Increases Adherence to Colorectal Cancer Screening Over 9 Years: a Randomized Trial.集中式计划加阶梯式支持可提高结直肠癌筛查的 9 年依从性:一项随机试验。
J Gen Intern Med. 2022 Apr;37(5):1073-1080. doi: 10.1007/s11606-021-06922-2. Epub 2021 May 28.
6
A stepped randomized trial to promote colorectal cancer screening in a nationwide sample of U.S. Veterans.一项促进美国退伍军人全国样本结直肠癌筛查的阶梯式随机试验。
Contemp Clin Trials. 2021 Jun;105:106392. doi: 10.1016/j.cct.2021.106392. Epub 2021 Apr 3.

本文引用的文献

1
Adherence to colorectal cancer screening measured as the proportion of time covered.以时间覆盖率衡量的结直肠癌筛查依从性。
Gastrointest Endosc. 2018 Aug;88(2):323-331.e2. doi: 10.1016/j.gie.2018.02.023. Epub 2018 Feb 23.
2
A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial.一项为期5年的随机试验表明,一个支持力度逐步增加的集中式邮寄项目可提高结直肠癌筛查指南的依从性。
Cancer. 2017 Nov 15;123(22):4472-4480. doi: 10.1002/cncr.30908. Epub 2017 Jul 28.
3
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.结直肠癌筛查:美国预防服务工作组推荐声明。
JAMA. 2016 Jun 21;315(23):2564-2575. doi: 10.1001/jama.2016.5989.
4
Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test.粪便结直肠癌筛查试验结果呈阳性后,结肠镜检查时间延长的后果。
Clin Gastroenterol Hepatol. 2016 Oct;14(10):1445-1451.e8. doi: 10.1016/j.cgh.2016.05.017. Epub 2016 May 19.
5
Defining and measuring adherence to cancer screening.定义和衡量癌症筛查的依从性。
J Med Screen. 2016 Dec;23(4):179-185. doi: 10.1177/0969141316630766. Epub 2016 Mar 4.
6
Hepatocellular Carcinoma Surveillance Among Cirrhotic Patients With Commercial Health Insurance.商业健康保险覆盖的肝硬化患者中的肝细胞癌监测
J Clin Gastroenterol. 2016 Mar;50(3):258-65. doi: 10.1097/MCG.0000000000000411.
7
Electronic medical records and prevention quality: the prevention index.电子病历与预防质量:预防指数
Am J Prev Med. 2007 Oct;33(4):291-6. doi: 10.1016/j.amepre.2007.05.011.
8
Methods for evaluation of medication adherence and persistence using automated databases.使用自动化数据库评估药物依从性和持续性的方法。
Pharmacoepidemiol Drug Saf. 2006 Aug;15(8):565-74; discussion 575-7. doi: 10.1002/pds.1230.
9
The Prevention Index: using technology to improve quality assessment.预防指数:利用技术改进质量评估
Health Serv Res. 2004 Jun;39(3):511-30. doi: 10.1111/j.1475-6773.2004.00242.x.
10
Analysis of case-control studies of the efficacy of screening for cancer: How should we deal with tests done in persons with symptoms?
Am J Epidemiol. 1998 Jun 15;147(12):1099-102. doi: 10.1093/oxfordjournals.aje.a009407.